Unsubstanciated, meaningless crap.
If this is not misleading the market i don't know what is.
1/ Open label, single centre trials are totally meaningless in getting a new drug approved.
In fact, they are regarded in the scientific world as being set up solely for the purpose of boosting penny-dreadful biotech stocks - and as such are actually a huge red flag to regulators and serious investors
( there are some very narrow exceptions - ie, they are sometimes legitimately used and accepted for expanding the conditions that an already approved drug can be used for)
They are NEVER employed for getting a new drug approved as they have none of the scientific rigor needed for this - let alone for powerful new psycodelics.
2/ Non peer reviewed reports written and released by the company of 5 patients results is an absolute joke.
Willian Ley should hang his head in shame for his statements about the value of these trials - and for these pathetic and scientifically meaningless "results" he just signed off on and released.
Don't get sucked in by these Disallowed salesmen's BS scientific jargon and spin. It is a con.
I give you my word of honour - Halucinex is a dog.
PS, By the way, lol..
Whatever happened to the much touted, no committment, open ended, open priced deal to off-load Halucinex to another failing, deap-in-debt, penny dreadful in the USA - in that very vaguely worded and highly suss deal put together by VIT BOD's close mate and parasite of choice >> ie, Everblue?
Just more - like these trial results - meaningless and misleading Scotch mist?
- Forums
- ASX - By Stock
- Ann: Halucenex Phase II Clinical Trial Update
Unsubstanciated, meaningless crap.If this is not misleading the...
-
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ME1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.0¢ |
Change
-0.007(41.2%) |
Mkt cap ! $1.416M |
Open | High | Low | Value | Volume |
1.6¢ | 1.6¢ | 1.0¢ | $225.3K | 17.98M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
23 | 3922713 | 1.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.1¢ | 125057 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
23 | 3922713 | 0.010 |
4 | 1000444 | 0.009 |
6 | 1192807 | 0.008 |
5 | 727858 | 0.007 |
7 | 2215664 | 0.006 |
Price($) | Vol. | No. |
---|---|---|
0.011 | 125057 | 2 |
0.012 | 606062 | 4 |
0.013 | 1047920 | 3 |
0.014 | 630616 | 6 |
0.015 | 1075142 | 3 |
Last trade - 16.10pm 20/06/2024 (20 minute delay) ? |
Featured News
ME1 (ASX) Chart |
The Watchlist
HAR
HARANGA RESOURCES LIMITED.
Peter Batten, MD
Peter Batten
MD
Previous Video
Next Video
SPONSORED BY The Market Online